Economics of cardiac adverse events after smallpox vaccination: lessons from the 2003 US Vaccination Program
- PMID: 18284356
- DOI: 10.1086/524380
Economics of cardiac adverse events after smallpox vaccination: lessons from the 2003 US Vaccination Program
Abstract
Of >39,000 civilian public health responders vaccinated against smallpox in 2003, 203 reported cardiovascular adverse events (CAEs). An association exists between the US vaccinia strain and myocarditis and/or pericarditis ("myo/pericarditis" [MP]). Other associations are inconclusive. We used surveillance and follow-up survey data of CAE case patients to estimate the resources used during the 2003 smallpox vaccination program and used a probabilistic model to estimate the potential costs of CAEs in a mass vaccination campaign. For every million adult vaccinees, 3001 CAEs (including 351 MP cases) would occur, with >92% in revaccinees. CAEs would require a median of 5934 outpatient visits, 1786 emergency department visits, 533 days in general wards, 132 days in intensive care units, 5484 cardiac enzymes tests, 3504 electrocardiograms, 3049 chemistry tests, 2828 complete blood counts, and 1444 transthoracic echocardiograms, among other procedures. CAEs would reduce productivity (15,969 work days lost) and cost $11 per vaccinee. In a mass vaccination campaign, the care of a sizable number of CAEs would be resource intensive.
Similar articles
-
US Civilian Smallpox Preparedness and Response Program, 2003.Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S157-67. doi: 10.1086/524751. Clin Infect Dis. 2008. PMID: 18284355
-
Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January-October 2003.Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S242-50. doi: 10.1086/524747. Clin Infect Dis. 2008. PMID: 18284365
-
Follow-up of cardiovascular adverse events after smallpox vaccination among civilians in the United States, 2003.Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S251-7. doi: 10.1086/524741. Clin Infect Dis. 2008. PMID: 18284366
-
The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program.Vaccine. 2005 Mar 18;23(17-18):2078-81. doi: 10.1016/j.vaccine.2005.01.012. Vaccine. 2005. PMID: 15755574 Review.
-
Smallpox vaccination and myopericarditis: a clinical review.J Am Coll Cardiol. 2004 May 5;43(9):1503-10. doi: 10.1016/j.jacc.2003.11.053. J Am Coll Cardiol. 2004. PMID: 15120802 Review.
Cited by
-
The social, political, ethical, and economic aspects of biodefense vaccines.Vaccine. 2009 Nov 5;27 Suppl 4(Suppl 4):D23-7. doi: 10.1016/j.vaccine.2009.08.054. Vaccine. 2009. PMID: 19837281 Free PMC article. Review.
-
The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform.Vaccine. 2021 May 21;39(22):3067-3080. doi: 10.1016/j.vaccine.2020.08.050. Epub 2020 Oct 17. Vaccine. 2021. PMID: 33077299 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical